StockData
AVITA Medical, Inc. logo

AVITA Medical, Inc. (RCEL) stock

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$16.83+1.06 (+6.72%)

Close on Nov 18, 2026Market cap $520.50MP/E –Yield –

AVITA Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

AVITA Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$24.62M. For fiscal 2025 it was -$32.21M. The highest annual figure on record is -$13.33M in fiscal 2018.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$32.21M–
FY2024Dec 31, 2024-$58.07M–
FY2023Dec 31, 2023-$39.39M–
FY2021Jun 30, 2021-$26.80M–
FY2020Jun 30, 2020-$23.34M–
FY2019Jun 30, 2019-$20.27M–
FY2018Jun 30, 2018-$13.33M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$3.60M–
Q1 FY2026CQ1 2026Mar 31, 2026-$10.09M–
Q4 FY2025CQ4 2025Dec 31, 2025-$4.77M–
Q3 FY2025CQ3 2025Sep 30, 2025-$6.15M–
Q2 FY2025CQ2 2025Jun 30, 2025-$10.75M–
Q1 FY2025CQ1 2025Mar 31, 2025-$10.53M–
Q4 FY2024CQ4 2024Dec 31, 2024-$9.65M–
Q3 FY2024CQ3 2024Sep 30, 2024-$10.97M–
Q2 FY2024CQ2 2024Jun 30, 2024-$15.43M–
Q1 FY2024CQ1 2024Mar 31, 2024-$22.01M–
Q4 FY2023CQ4 2023Dec 31, 2023-$11.16M–
Q3 FY2023CQ3 2023Sep 30, 2023-$9.48M–
Q2 FY2023CQ2 2023Jun 30, 2023-$9.40M–
Q1 FY2023CQ1 2023Mar 31, 2023-$9.36M–
Q4 FY2021CQ2 2021Jun 30, 2021-$4.07M–
Q3 FY2021CQ1 2021Mar 31, 2021-$8.87M–
Q2 FY2021CQ4 2020Dec 31, 2020-$5.94M–
Q1 FY2021CQ3 2020Sep 30, 2020-$7.92M–
Q4 FY2020CQ2 2020Jun 30, 2020-$6.04M–
Q3 FY2020CQ1 2020Mar 31, 2020-$7.63M–
Q2 FY2020CQ4 2019Dec 31, 2019-$4.70M–
Q1 FY2020CQ3 2019Sep 30, 2019-$4.97M–

More AVITA Medical figures

See a number that looks wrong?